Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

Despite mass drug administration programmes with praziquantel, the prevalence of schistosomiasis remains high. A vaccine is urgently needed to control transmission of this debilitating disease. As some promising schistosomiasis vaccine candidates are moving through pre-clinical and clinical testing,...

Descripción completa

Detalles Bibliográficos
Autores principales: Driciru, Emmanuella, Koopman, Jan Pieter R., Cose, Stephen, Siddiqui, Afzal A., Yazdanbakhsh, Maria, Elliott, Alison M., Roestenberg, Meta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970007/
https://www.ncbi.nlm.nih.gov/pubmed/33746974
http://dx.doi.org/10.3389/fimmu.2021.635985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970007/
https://www.ncbi.nlm.nih.gov/pubmed/33746974
http://dx.doi.org/10.3389/fimmu.2021.635985

Ejemplares similares